Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:57:16.651Z.
Calculation as of: 2026-10-06T20:57:16.651Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8c49465b29cefd47847e7fc901c6d20b09f101de13d3ea96f762810498d8f388
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
INmune Bio, Inc.
Market Cap
$49.71M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.25M
Operating Cash Flow Yield
N/A
TTM Avg
1.36%
3Y Avg
0.72%
5Y Avg
0.95%
Market Cap
$50.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$50.28M
Operating Cash Flow Yield
48.46%
TTM Avg
50.32%
3Y Avg
31.17%
5Y Avg
36.60%
Market Cap
$48.89M
Operating Cash Flow Yield
N/A
TTM Avg
4.17%
3Y Avg
3.77%
5Y Avg
3.39%
Market Cap
$48.76M
Operating Cash Flow Yield
N/A
TTM Avg
10.62%
3Y Avg
10.36%
5Y Avg
10.36%
Market Cap
$48.53M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| INmune Bio, Inc. (INMB) | $49.71M | N/A | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.45M | N/A | N/A | N/A | N/A |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | N/A | 1.36% | 0.72% | 0.95% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $50.28M | 48.46% | 50.32% | 31.17% | 36.60% |
| Sensus Healthcare, Inc. (SRTS)vs › | $48.89M | N/A | 4.17% | 3.77% | 3.39% |
| TELA Bio, Inc. (TELA)vs › | $48.77M | N/A | N/A | N/A | N/A |
| Microbot Medical Inc. (MBOT)vs › | $48.76M | N/A | 10.62% | 10.36% | 10.36% |
| Apollomics, Inc. (APLM)vs › | $48.53M | N/A | N/A | N/A | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
